ClinicalTrials.gg

Zambon SpA clinical trials

The registry lists 24 studies whose lead sponsor is Zambon SpA or one of 1 company grouped under it. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 15, 2026.

Our grouping of 2 registry names, not the registry’s. See them and correct one ↓

What it is testing

The drugs Zambon SpA’s studies test, most studies first; none is open now — 9 drugs with a page of their own. Each count opens the studies in search.

Studies, none open

All 24 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Completed2083%
  • Stopped early417%Terminated 3 · Withdrawn 1

Phase

  • Phase 39
  • Phase 17
  • Phase 23
  • Phase 41

Where

  • Spain11
  • Germany9
  • United Kingdom8
  • Belgium7
  • Italy7
  • France7

Over the years

  1. 12
  2. 13
  3. 14
  4. 15
  5. 16
  6. 17
  7. 18
  8. 919
  9. 20
  10. 21
  11. 22
  12. 23
  13. 24
  14. 25
  15. 026

By the year each study started; 1 started before 2012. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Zambon SpA.

  • Zambon SpA
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    23 studies
  • Zambon SAU
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →

Studies

Recruiting first, then most recently updated. Showing 24 of 24.